Total Payments
$2,575
2024 Payments
$372.55
Companies
13
Transactions
99
Medicare Patients
192
Medicare Billing
$108,732
Payment Breakdown by Category
Food & Beverage$2,571 (99.8%)
Education$3.93 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,571 | 98 | 99.8% |
| Education | $3.93 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $479.22 | 25 | $0 (2022) |
| ITI, Inc. | $418.50 | 10 | $0 (2023) |
| Lundbeck LLC | $341.02 | 19 | $0 (2019) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $254.71 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $218.68 | 6 | $0 (2020) |
| Allergan, Inc. | $189.07 | 7 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $180.34 | 11 | $0 (2019) |
| ABBVIE INC. | $152.54 | 3 | $0 (2022) |
| Axsome Therapeutics, Inc. | $117.84 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $79.80 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $372.55 | 6 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($254.71) |
| 2023 | $402.76 | 9 | ITI, Inc. ($402.76) |
| 2022 | $187.48 | 5 | ABBVIE INC. ($152.54) |
| 2020 | $136.11 | 7 | Sunovion Pharmaceuticals Inc. ($54.68) |
| 2019 | $783.05 | 31 | Allergan Inc. ($177.85) |
| 2018 | $332.62 | 20 | Sunovion Pharmaceuticals Inc. ($116.25) |
| 2017 | $360.07 | 21 | Lundbeck LLC ($153.31) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $129.99 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: PSYCHIATRY | ||||||
| 01/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $117.84 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: PSYCHIATRY | ||||||
| 06/22/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $122.74 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: PSYCHIATRY | ||||||
| 03/29/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: PSYCHIATRY | ||||||
| 03/02/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $84.07 | General |
| Category: PSYCHIATRY | ||||||
| 02/15/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: CNS | ||||||
| 04/28/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: CNS | ||||||
| 04/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $121.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $36.47 | General |
| Category: CNS | ||||||
| 08/31/2020 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2020 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 49 | 469 | $52,984 | $34,376 |
| 2022 | 3 | 39 | 292 | $34,260 | $22,743 |
| 2021 | 3 | 57 | 433 | $46,934 | $31,366 |
| 2020 | 3 | 47 | 339 | $33,410 | $20,249 |
Total Patients
192
Total Services
1,533
Medicare Billing
$108,732
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 209 | $23,175 | $14,857 | 64.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 17 | 208 | $21,785 | $14,229 | 65.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 52 | $8,023 | $5,290 | 65.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 116 | $12,898 | $8,709 | 67.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 11 | 121 | $12,709 | $8,668 | 68.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 55 | $8,654 | $5,365 | 62.0% |
| 90838 | Psychotherapy with evaluation and management visit, 60 minutes | Office | 2021 | 18 | 193 | $26,766 | $18,072 | 67.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 194 | $13,058 | $8,783 | 67.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 46 | $7,110 | $4,511 | 63.4% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 14 | 152 | $20,843 | $13,758 | 66.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 152 | $8,273 | $4,251 | 51.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 35 | $4,294 | $2,239 | 52.2% |
About Dr. Deborah Haynes, MD
Dr. Deborah Haynes, MD is a Psychiatry healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801939129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Haynes, MD has received a total of $2,575 in payments from pharmaceutical and medical device companies, with $372.55 received in 2024. These payments were reported across 99 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,571).
As a Medicare-enrolled provider, Haynes has provided services to 192 Medicare beneficiaries, totaling 1,533 services with total Medicare billing of $108,732. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Bellevue, WA
- Active Since 02/15/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1801939129
Products in Payments
- CAPLYTA (Drug) $673.21
- LATUDA (Drug) $479.22
- REXULTI (Drug) $478.42
- VRAYLAR (Drug) $341.61
- Trintellix (Drug) $234.47
- Auvelity (Drug) $117.84
- TRINTELLIX (Drug) $81.28
- BELSOMRA (Drug) $79.80
- SUNOSI (Drug) $48.65
- SPRAVATO (Drug) $40.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bellevue
Dr. Arifulla Khan, Md, MD
Psychiatry — Payments: $457,425
Psychiatry $457,425
Dr. Patricia Paddison, M.d, M.D
Psychiatry — Payments: $102,774
Psychiatry $102,774
Dr. Mary-Ann Bolte, M.d, M.D
Psychiatry — Payments: $5,055
Psychiatry $5,055
Dr. Eugene Oliveto, Md, MD
Psychiatry — Payments: $2,494
Psychiatry $2,494
Tatjana Deretic, M.d, M.D
Psychiatry — Payments: $1,806
Psychiatry $1,806
Russell Vandenbelt, M.d, M.D
Psychiatry — Payments: $1,310
Psychiatry $1,310